Skip to main content
. 2020 Jun 3;20:851. doi: 10.1186/s12889-020-09012-w

Table 2.

Prevalence of HIV, hepatitis and co-infections in PWID in two urban settings in Mozambique, 2013–2014

Characteristics PWID Study Population
n % unweighted RDS-weighted % (95%CI)
HIV infected (N = 445a) 204 45.8 44.9 (37.6–52.3)
HBV infected (N = 490a) 164 33.5 32.8 (26.3–39.5)
HCV infected (N = 446a) 163 36.5 38.3 (30.6–45.9)
HIV/HBV co-infection (N = 444a) 59 13.3 13.1 (7.2–18.9)
HIV/HCV co-infection (N = 424a) 124 29.2 29.5 (22.2–36.8)
HIV/HBV/HCV co-infection (N = 423a) 40 9.5 9.2 (3.7–14.7)

a Denominator reflects the number of participants who consented to testing for each biomarker